Clinical trial Recruiting at 1 site Interventional Ages 14 and up

Caregiver-Adolescent Dating Violence Prevention Program for Sexual and Gender Diverse Youth

Official title: Relationship Abuse Prevention Intervention Implemented With Sexual and Gender Diverse Youth and Their Caregivers - Pilot Trial

Run by University of Pittsburgh · NCT07718022 · Data updated 2026-11-12

This pilot tests FLARE, a dating-violence prevention program for SGDY and their trusted adults to see if it’s acceptable, feasible, and ready to use in real settings.

More Sexual and Gender Minorities trials

Quick facts

Study typeInterventional
Ages14 Years and up
SexAll
Enrollment108 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedAugust 1, 2027
Study endsJuly 1, 2028
Registry record updatedAugust 10, 2026
Trial IDNCT07718022 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are SGDY youths aged 14–18 who identify as sexually or gender diverse, speak English, and can identify a caregiver who can participate.

Probably not a fit

Participants or caregivers who cannot participate in the in-person session or do not engage with the program may not experience the intended benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial will compare FLARE to a wait-list control over four weeks, assessing acceptability, feasibility, and fidelity while exploring potential changes in behavior. FLARE includes an in-person full-day session, two virtual large group sessions, and asynchronous components (website, workbook, and card game) designed for SGDY and their caregiver. The study uses a dyadic design, requiring a matched caregiver and adolescent from the SGDY community, with outcomes measured through exploratory behavioral changes.Participants will travel to Pittsburgh for one in-person event.

Why it matters

Potential benefit: If successful, the program could provide a scalable approach to reduce dating violence among SGDY youth by engaging their trusted adults.

How similar studies have gone: Previous work in youth dating-violence prevention supports the feasibility of caregiver-inclusive approaches, but this specific SGDY-focused, dyadic FLARE program is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* SGDY eligibility includes:

  1. ages 14 to 18
  2. identifies as sexually or gender diverse (e.g., gay, lesbian, bisexual, queer, transgender, or nonbinary)
  3. uses English
  4. willing to travel to Pittsburgh for 1 in-person event; and
  5. can identify a caregiver who can also participate.

Caregivers eligibility includes:

1. age 18 or older;
2. a caregiver of an SGDY ages 14 to 18;
3. uses English;
4. willing to travel to Pittsburgh for 1 in-person event; and
5. has a child participating in this study. Caregivers can include parents or any other person whom the adolescent identifies as a trusted adult in their life. We will only enroll 1 caregiver for each SGDY; because this is a dyadic study each adolescent needs a matched participating caregiver and vice versa.

Exclusion Criteria:

* Does not meet eligibility criteria
* Incarcerated during the study
* Unable to provide verbal or REDCap consent or assent

Where it's running

  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Maya I Ragavan — University of Pittsburgh
  • Study coordinator: Maya Ragavan, MD
  • Email: ragavanm@chp.edu
  • Phone: 6506449954

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.